Dicerna Pharmaceuticals

$24.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.39 (-1.58%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell DRNA and other stocks, options, and ETFs commission-free!

About DRNA

Dicerna Pharmaceuticals, Inc. Common Stock, also called Dicerna Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA. The listed name for DRNA is Dicerna Pharmaceuticals, Inc. Common Stock.

CEO
Douglas M. Fambrough
Employees
187
Headquarters
Lexington, Massachusetts
Founded
2007
Market Cap
1.82B
Price-Earnings Ratio
Dividend Yield
Average Volume
557.77K
High Today
$24.38
Low Today
$23.27
Open Price
$24.14
Volume
549.28K
52 Week High
$27.68
52 Week Low
$11.75

Collections

DRNA Earnings

-$0.58
-$0.20
$0.17
$0.55
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, After Hours

You May Also Like